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Glutathione s transferases (GSTs) consist of a superfamily
of dimeric phase II metabolic enzymes that catalyse the con-
jugation of reduced glutathione with various electrophilic
compounds (1). The human GST genes are divided into four
major subfamilies designated as GST or A, GST or M, GST
or T, and GST or P (2). The class  GST gene exists as a
single functional gene in human, whereas class  ,  , and 
families contain multiple distinct genes, sharing ~55, 65,
and 50% identity, respectively (3). Two of these subfamilies,
GSTM1 and GSTT1, show deletion polymorphism (4), and
the GSTP1 gene has polymorphism loci within its coding re-
gion, of which well-known are an A- to -G transition at nu-
cleotide position 1,578 causing an isoleucine-to-valine substi-
tution at codon 105 (Ile
105Val) in exon 5, a C- to -T base change
at position 2,293 giving rise to the replacement of alanine to
valine at the amino acid position 114 (Ala
114Val) in exon 6
(5, 6).
Human cytosolic GSTs have been well characterized and
known to be polymorphic, with different polymorphism fre-
quencies by ethnicity. The percentage of individuals who do
not express the GSTM1 enzyme due to a homozygous gene
deletion is higher in Caucasians and Asians than in Africans
(7, 8). About 60% of Asians, 40% of Africans and 20% of
Caucasians do not express the GSTT1 enzyme (9). These ho-
mozygous gene deletions, called null genotypes, are denoted
as GSTM1*0/*0 and GSTT1*0/*0. Polymorphisms of GSTM
1, GSTT1, and GSTP1 have been shown to be associated with
susceptibility to various forms of cancer, particular those cau-
sed by cigarette smoking (9), resistance to chemotherapy treat-
ment (3), and disease outcomes (10). We analyzed the fre-
quencies of the major polymorphisms of GSTM1, GSTT1
and GSTP1 in a Korean male population to provide a basic
database for future clinical and genetic studies concerning va-
riability in the response and/or toxicity to drugs known to be
substrates for GSTs. 
The study subjects are healthy individuals recruited from
the health promotion center, Samsung Medical Center with-
out any pathology. A total of 1,051 unrelated male Korean
subjects (mean age, 50.7 yr; range, 35-76 yr) participated in
this study. Deletion status of GSTM1 and GSTT1 was simul-
taneously determined by a multiplex polymerase chain reac-
tion method (11). GSTM1 and GSTT1 genes were amplified
using the following primers: 5′ GAA CTC CCT GAA AAG
CTA AAG C 3′ and 5′ GTT GGG CTC AAA TAT ACG
GTG G 3′ for GSTM1 and 5′ TTC CTT ACT GGT CCT
CAC ATC TC 3′ and 5′ TCA CCG GAT CAT GGC CAG
CA 3′ for GSTT1. As an internal control, exon 7 of the CYP1
A1 gene was co-amplified using the primers 5′ GAA CTG
CCA GGC CAG CA 3′ and 5′ CAG CTG CAT TTG GAA
GTG CTC 3′ . Agarose gel electrophoresis (1%) resolved am-
plified DNA fragments of 480, 312, and 215 bp for GSTT1,
CYP1A1 and GSTM1, respectively. To determine the geno-
types at codon 105 and 114, respectively, the exon 5 and exon
6 of the GSTP1 gene were amplified using the following pri-
mers: 5′ TGT GTG GCA GTC TCT CAT CC 3′ and 5′ G-
AA GCC CCT TTC TTG TTC A 3′ for the exon 5 and 5′ G-
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The isoenzymes of the glutathione s transferase (GST) family play a vital role in
phase II of biotransformation of many substances. Using a multiplex polymerase
chain reaction and a direct sequencing analysis, the frequencies of GSTM1, GSTT1,
and GSTP1 polymorphisms were evaluated in 1,051 Korean male subjects. We
found that 53.8% of the individuals had the GSTM1 null genotype and 54.3% had
the GSTT 1 null genotype. The genotypic distribution of GSTP1 was Ile105/Ile105 in
68.4%, Ile105/ Val105 in 29.1% and Val105/Val105 in 2.5%. The most frequently observed
combination of GSTM1, GSTP1 and GSTT1 genotypes was Null type/Ile105/Ile105/Null
type, while the combination of Non-null type/Val105/Val105/Non-Null type was not
observed. We found that the genotype distributions of three GST isoenzymes in
the Koreans are similar to those reported in Asians and previously reported Kore-
ans. We believe our results, which are represented by a large population, are reli-
able estimates of the frequencies of the polymorphic GST alleles in the Koreans
and will help future researches on GST polymorphisms.
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CAAGCAGAGGAGAA TCT GG 3′ and 5′ CTA AGC C
CA TCC CCT AGG TC 3′ for the exon 6, and directly se-
quenced on ABI Prism 3,700 Genetic analyzer (Applied Bio-
systems, Foster City, CA, U.S.A.) using the ABI Prism BigDye
Terminator Cycle Sequencing Ready Reaction kit (Applied
Biosystems). 
The null GSTM1 and GSTT1 genotypes were found in
53.8% and 54.3% of the individuals, respectively. Twenty-
nine percent had the null genotype for both genes. The only
genetic polymorphism in GSTP1 was Ile
105Val in exon 5. The
genotype distribution of this locus was Ile105/Ile105 in 68.4%,
Ile105/Val105 in 29.1%, and Val105/Val105 in 2.5%, which is in
Hardy-Weinberg equilibrium by 
2 test. The allele frequency
of Ile at codon 105 was 0.83. We examined the distribution
and frequencies of the combined genotypes of GSTM1, GSTP
1 and GSTM1. For genotype combination analysis, there were
1,021 samples available where the genotyping was successful
for each of three GST genes. Eleven out of 12 possible com-
binations were observed (Table 1). Five genotype combina-
tions showed frequencies greater than 10%. The most fre-
quently observed combination was Null type/Ile105/Ile105/Null
type, while Non-null type/Val105/Val105/Non-Null type was
not observed.
Polymorphisms in GST genes can affect the expression le-
vels of the GST enzymes. Since GST enzymes play a vital role
in cellular defense against environmentally toxic compounds,
such as carcinogens, polymorphisms of GST gene can increase
subsceptibility to diseases caused by such xenobiotics. We ob-
served 53.8% of the Korean population were homozygous
for the GSTM1 deletion. This frequency is similar to that re-
ported in a previous study that analyzed the GSTM1 poly-
morphism in Koreans (12, 13) and also to those reported in
other studies in Caucasians and Japanese (Table 2) (14, 15).
We observed 54.3% of these Koreans were homozygous for
the GSTT1 deletion. This frequency is similar to that report-
ed in other studies that analyzed the GSTT1 polymorphism
in Koreans and Japanese (12, 15), however higher than that
observed in Caucasian population (Table 2) (7, 14, 16). The
frequency of double nulls observed in the present study (29.1
%) is higher than that observed in a Caucasian population
(14), South Indians, and Afro-Americans (17). No frequency
data are available for double nulls in other Asians including
Japanese and Chinese, and Koreans. Three different GSTP1
alleles, GSTP 1a, GSTP1b, and GSTP1c, have been described
(6). GSTP1b differs from GSTP1a by having an A      G tran-
sition at nucleotide +313, changing codon 105 from ATG
(Ile) to GTC (Val). GSTP1c is characterized by two nucleotide
transitions, A       G at +313, the same as observed in GSTP
1b, and C    T at +341, changing codon 114 from GCG
(Ala) to GTG (Val) (5). In this study, we observed 68.4% had
the Ile105/Ile105 genotype, 29.1% had the Ile105/Val105 genotype,
and 2.5% had the Val105/Val105 genotype, with an allelic fre-
quency 0.83 for the Ile allele. The polymorphism GCG (Ala)
GTG (Val) at codon 114 was not observed. These results
are similar to those reported in other studies in Koreans (18)
and other Asians (19, 20). The Val105/Val105 genotype was more
frequent in Caucasians than in Asians (Table 3) (21). Little
has been known about the combined effect of the GSTM1,
GSTT1, and GSTP1 genotypes. For all three polymorphisms,
previous studies reported association with various diseases,
however subsequent studies validating these findings are lac-
king. Recent reports and meta-analysis show that single GST
gene polymorphisms do not significantly increase risks to vari-
ous diseases (22-24), suggesting investigations on combined
Combination Frequency  %
(GSTM1/GSTP1/GSTT1) (No. of individuals)
Non-null type/Ile105/Ile105/Non-null type 14.89 (152)
Non-null type/Ile105/Ile105/Null type 18.02 (184)
Non-null type/Ile105/Val105/Non-null type 6.07 (62)
Non-null type/Ile105/Val105/Null type 6.56 (67)
Non-null type/Val105/Val105/Null type 1 (1)
Null type/Ile105/Ile105/Null type 18.71 (191)
Null type/Ile105/Ile105/Non-null type 16.65 (170)
Null type/Ile105/Val105/Non-null type 7.93 (81)
Null type/Ile105/Val105/Null type 10.19 (104)
Null type/Val105/Val105/Non-null type 0.29 (3)
Null type/Val105/Val105/Null type 0.59 (6)
Total 100 (1,021)
Table 1. Frequency distribution of the combined genotypes for
the GSTM1, GSTT1 and GSTP1 polymorphism
Frequency, % (95% confidence intervals)
GSTM1*0/*0 53.7 55.6 53.5 51.3 53.8
(46.3-61.1) (49.3-61.9) (46.8-60.2) (43.3-59.3) (50.8-56.9)
GSTT1*0/*0 53.1 55.1 14.7 54.0 54.3
(45.7-60.5) (48.9-61.4) (10.2-19.8) (46.2-62.0) (51.3-57.4)
Combined Not Not 7.5 Not 29.1
reported reported (4.4-11.9) reported (26.4-31.9)
Table 2. Frequencies of the homozygous deletions at GSTM1,
GSTT1 loci and their combination in present study, in compari-
son with those on other studies in Koreans and other populations
Choi et al. Jang et al. Caucasians Japanese The present
(12) (13) (14) (15) study
n=177 n=243 n=213 n=150 n=1,037
GST
genotype
Yim et al. (18) (n=94) 61 37 2 0.79
Jee et al. (29) (n=707) 66.8 29.3 3.9 0.81
Caucasians (21) (n=622) 47.9 40.8 11.3 0.68
Japanese (20) (n=257) 71.6 25.3 3.1 0.84
Chinese (19) (n=119) 70.6 28.6 0.8 0.71
The present study (n=1,030) 68.4 29.1 2.5 0.83
Table 3. Frequencies of GSTP1 polymorphisms in the present
study, in comparison those in other studies on Koreans and other
populations
% Frequency distribution
Population
Ile105/ Ile105/ Val105/
Ile105 Val105 Val105
Ile allele
frequencyGSTM1, GSTT1 and GSTP1 Polymorphisms 1091
genotypes of GSTM1, GSTT1 and GSTP1, or even in rela-
tion to other metabolizing enzymes are needed. Several studies
have reported a relationship between combination of the GST
genotype and risk of various diseases such as chronic lympho-
cytic leukemia, thyroid cancer and breast cancer (25-27) and
some of them suggested a possible synergistic effect between
GST genotypes (25, 27). In present study concerning combi-
nation of the GSTM1, GSTP1 and GSTT1 genotypes, note-
worthy points are lack of Non-null type/Val105/Val105/Non-
Null type and presence of Null type/Val105/Val105/Null type.
Although finding might need further confirmation in other
healthy populations, it suggests a potential difference in gene-
tic susceptibility to various diseases in Korean population. Al-
though our study included only male subjects, given that the
genotype frequencies are not affected by sex in general (28),
our data can represent the population genotype frequencies.
Indeed, our data did not show any significant differences when
compared with other studies that included female subjects
(13, 28). 
In conclusion, genotype data for polymorphic variants of
GST genes provide further evidence for ethnic variations in
metabolism and disposition. The notable merit of this study
is that we genotyped all three major GST enzymes, GSTM1,
GSTP1, and GSTT1, in the largest population studied, report-
ing the frequency distribution of the combined genotypes.
We believe these data will help genetic studies on GSTM1,
GSTT1 and GSTP1 polymorphisms in association with dis-
ease risks and drug effects in Koreans.
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